FILA AURA的研发将"稳"拆解为多重技术落点：中底内置FILA独家「魔鬼鱼稳定板」，鞋面采用Sorona高端服装面料，鞋面质感提升，鞋面剪裁更修饰，模糊运动与商务边界；鞋楦专为亚洲人脚型定制，修饰脚型同时给到全天穿着的包裹感。

1、米6体育 乌拉圭首战前，阿劳霍训练中肌肉撕裂，此后贝尔萨的球队小组出局，他一分钟没踢。

不过这笔交易实际操作起来难度不小，最大的障碍就是薪资问题。米6体育西班牙U19国家队在本届赛事中展现出绝对统治力，一路高歌猛进杀入决赛。

2、葡萄牙新帅给C罗平反，批评队友支持不够：所谓豪华中场我没看到

上半年集团总营收12.9亿欧元，同比增长5%，按固定汇率计算增长9%，营业利润达到2.454亿欧元，同比增长9.1%，净利润1.647亿欧元，同比增长7.3%。

3、中办、国办印发《关于全力做好防汛抗旱工作的通知》

"波罗说道。

4、亚洲虎变亚洲仓鼠了！韩国不敌南非引国内怒批，像集体得了肠胃炎

标哥做过几期揭露加盟商套路的视频，他最终得出的结论是：24年往后，量贩零食行业稳赚不赔的，不是零食生意，不是加盟商，只有品牌方。

5、三联药都压不住的高血压，还遇上肾损+高尿酸？借助AI快速调整方案

模型接收视觉画面、语言指令和机器人状态，直接输出动作，让感知、理解和控制尽可能在一个模型中完成。

滞后的总结归纳可能会过度理想化。

甘伯体育城的初步检查结果显示，这位荷兰国脚将缺阵三到四个月。

6、世界杯进球含金量榜单！梅西7次主罚点球罚丢3次 姆巴佩含金量最高

这套中场架构兼顾了经验与活力，硬度与技术的搭配更为均衡。

进攻端，澳大利亚主要依靠两种手段：一是定位球头球，利用苏塔的身高优势在角球和任意球中寻找机会；二是快速反击，断球后直接长传找边锋，利用速度冲击对手身后。

7、心衰患者吃半年“护心餐”，血脂大降！《Nutrients》最新：单纯地中海饮食 vs 联合Omega-3，24周干预，VLDL骤降

这主要得益于他们阵容的稳定性，基本保留了核心球员，只对部分位置进行微调。

尽管存在短期负面影响，滔搏称其将就线下销售安排致力与耐克保持紧密合作。

8、U17国足杀入亚洲杯决赛跟日本会师！核心将解决复出，值得期待

同一脚踝在不到一年内第三次扭伤，这是当时德容巴萨生涯最严重的一次伤病，休战超过五个月。

据当地官方估计，约有200万球迷涌上街头，与球队一同庆祝这历史性时刻。

考文垂方面则有兰帕德的个人关系加持，两人曾在德比郡和切尔西共事，但球队的平台吸引力显然不及纽卡。

9、召回多名技术型球员，国足6月集训强化进攻！带武磊只为凑够百场

（文｜出海参考，作者｜王璐，编辑｜罗文琴）Nextfin News — On July 22, latest research from Omdia showed that despite total market shipments dropping by over ten percent in the second quarter, Vivo—excluding its iQOO sub-brand—maintained its top position in the Indian smartphone market with 6.3 million units shipped. Yet despite its strength in the market, Vivo was unable to keep full control over its manufacturing plants in India. There is an unwritten law in the corporate world that market share acts as a moat and scale brings bargaining power. But in India, Vivo has just seen that principle turned on its head—and in a remarkably brutal fashion. On July 9, an official approval was finally granted. Dixon Technologies announced to the stock exchange that Vivo India received a clearance letter issued on July 8 by India’s Department for Promotion of Industry and Internal Trade. Under this approval, the manufacturing operations Vivo built over twelve years in India will formally be folded into a joint venture controlled fifty-one percent by a local partner. According to industry analyses, the new entity has a paid-up capital of just fifty million rupees—around three and a half million yuan—yet it is taking over a mega-factory designed for an annual capacity of over one hundred million units and backed by a workforce of more than ten thousand employees. Viewed in isolation, this transaction reads like a story of loss. But when placed back into the context of Vivo’s global footprint, its true nature changes entirely. India remains Vivo’s largest overseas market, ranking first in 2025 with 32.1 million shipments and a twenty-one percent market share, accounting for roughly one-third of the brand's total global volume. Overseas operations already contribute more than half of Vivo's global revenue, with targets set to raise that share to sixty percent this year and seventy percent by 2027. This shift in India does not merely affect a single regional market; it alters the structural load-bearing pillar of Vivo’s entire global strategy. With the Indian chapter coming to a close, Vivo now faces far more practical questions about its future: What exactly did this equity restructuring change, and how will the brand navigate its next phase of globalization? A Three-and-a-Half-Million Yuan Outlay for a Three-Hundred-Billion Revenue Business By securing a fifty-one percent controlling stake, Dixon leveraged its position to capture a cash cow with an annual revenue potential estimated between two hundred fifty billion and three hundred billion rupees—roughly twenty-one billion to twenty-five billion yuan. This revenue guidance originates directly from Dixon’s own management team. As early as May, Dixon founder Sunil Vachani revealed that the joint venture would handle approximately two-thirds of Vivo’s smartphone sales in India, representing over twenty million units annually. JPMorgan further projects that the joint venture will add around eleven million smartphone shipments in fiscal year 2027, scaling up to approximately twenty-two million units annually across fiscal years 2028 and 2029. From India's perspective, this outcome represents a decisive policy victory. Looking back at Vivo’s expansion abroad, its capital deployment in India consisted of substantial physical investments. According to an official press release issued by Vivo India in April 2023, the company outlined a total investment plan of seventy-five billion rupees. The first phase called for thirty-five billion rupees by the end of 2023, of which twenty-four billion had already been allocated alongside plans to inject an additional eleven billion rupees by year-end. The new facility in Greater Noida, Uttar Pradesh, spans roughly 169 acres—a site acquired back in 2018 that officially went into operation in mid-2024. It currently holds an annual production capacity of sixty million units, with plans to double that figure to one hundred twenty million upon full completion, rivaling the footprint of Samsung’s largest manufacturing plant in the country. By 2018, Vivo's earlier facility was already generating a monthly output of around one million units while employing nearly ten thousand local workers. What do these figures truly signify? They demonstrate that Vivo was never just a consumer brand in India; it had built an end-to-end manufacturing system, a local supply chain, and a massive employment ecosystem. The company replicated its battle-tested Chinese ground-sales model across India, extending from major metropolitan shopping centers down to rural retail shops across roughly seventy thousand touchpoints. It even transformed India into an export hub, shipping Indian-made smartphones to Thailand and Saudi Arabia for the first time in 2022, with export targets exceeding one million units in 2023. Yet after 2024, every one of these capital investments transformed into a distinct disadvantage at the negotiating table. Faced with mounting regulatory pressure, Vivo initiated discussions in 2024 with major domestic players including Tata Group, Murugappa Group, and Dixon Technologies to explore joint ventures or contract manufacturing options, though early negotiations stalled. In December 2024, Vivo signed a non-binding term sheet with Dixon Technologies, initiating a protracted government approval process that dragged on for nineteen months. Upon closing, the joint venture will purchase selected manufacturing assets from Vivo for an undisclosed amount, sign dedicated production and packaging agreements with Vivo India, handle a substantial share of its OEM orders, and retain the flexibility to manufacture for third-party brands down the line. With an initial capital commitment of just 25.5 million rupees, Dixon gains access to established assembly lines, skilled workers, an integrated supply chain, and guaranteed orders from a brand selling over thirty million phones a year. In return, Vivo retains only the right to continue selling smartphones in the Indian market alongside a forty-nine percent financial yield on equity. Using a newly incorporated entity with a registered capital of merely fifty million rupees to take control of an advanced industrial plant capable of producing over one hundred million units annually is virtually unprecedented in global business history. Vivo understood the gravity of the concessions, but faced with severe regulatory constraints, it was left with few alternatives. Why Did Stronger Sales Lead to Heavier Constraints? Under standard market conditions, Vivo’s operational execution in India was textbook perfect. According to data from market research firm Omdia, Vivo—excluding iQOO—led the Indian smartphone market throughout 2025 with 32.1 million shipments and a twenty-one percent market share, marking a nineteen percent year-over-year growth rate. Samsung trailed in second place with twenty-three million units and a fifteen percent share. By the fourth quarter, Vivo widened its lead even further, shipping 7.9 million units in a single quarter to capture twenty-three percent of the market. Securing the top spot in the world's second-largest smartphone market—a region absorbing roughly one hundred fifty-four million devices annually—should have been a landmark corporate victory after twelve years of dedicated effort. However, as policy priorities shifted unexpectedly, the very capital-heavy assets Vivo spent years building transformed into immobilized leverage against the company. In April 2020, India enacted Press Note 3, requiring case-by-case government review for all direct foreign investments originating from countries sharing a land border. This rule effectively blocked capital injection channels for Chinese entities. Over the following years, regulatory scrutiny targeting Chinese smartphone manufacturers steadily intensified. In July 2022, authorities accused Vivo India of illicitly remitting 624.76 billion rupees back to China under the guise of tax avoidance. Vivo was hardly the only brand reshaped by this changing regulatory framework. Enforcement agencies froze 55.51 billion rupees of Xiaomi India’s assets in a dispute that remains unresolved; OPPO received a customs tax demand totaling 43.89 billion rupees; Transsion's manufacturing subsidiary, Ismartu India, surrendered a 50.1 percent controlling stake to Dixon; and HKC’s joint venture with Dixon was approved under a seventy-four to twenty-six equity structure. Faced with these conditions, Vivo was forced into a harsh binary choice: abandon its sunk costs and hand over billions of rupees in physical plants and distribution networks, or accept majority control by a local partner in exchange for permission to remain in the market. The restructuring struck directly at the primary engine of Vivo’s international business. India is not just another regional market for Vivo; it is its largest overseas pillar. In March of last year during the Boao Forum for Asia, Vivo COO Hu Baishan emphasized two key realities to Bloomberg: India is Vivo's most critical international market, and with overseas sales contributing over half of total revenues, the company is aiming for sixty percent in 2026 and seventy percent by 2027. In essence, the restructuring in India does not just adjust a local subsidiary; it alters the foundational premise of Vivo’s global expansion story. The "deep localization" playbook—building local plants, hiring local workforces, and cultivating local component ecosystems—long viewed as an ideal blueprint for overseas expansion, saw its ownership structure unilaterally rewritten in its most prominent market. Without Direct Plant Ownership in India, How Will Vivo Secure One-Third of Its Global Footprint? From a strategic standpoint, Vivo officially characterizes its international methodology as "More Local, More Global." The strategy relies on manufacturing localization through plants in markets like India and Brazil; marketing localization via major cultural partnerships ranging from the Indian Premier League to official sponsorships at the UEFA European Championship; and channel localization by exporting its field-sales distribution networks. The effectiveness of this approach is undeniable, as evidenced by Vivo holding the top market position in both India and Indonesia. Yet Vivo’s challenges in India expose the inherent vulnerabilities of this model: an over-concentration in specific regional markets and the property-rights risk associated with capital-heavy physical infrastructure. Pushing "More Local" to its logical extreme means anchoring factories, workforces, and supply chain assets entirely within foreign legal jurisdictions. Under favorable conditions, these assets form competitive barriers; during regulatory shifts, they turn into operational exposure. The deeper Vivo planted its roots in India over twelve years, the less leverage it retained during structural negotiations. Another challenge lies in Vivo's limited footprint across premium segments and developed Western markets. In discussions with Bloomberg, Hu Baishan noted that Vivo has paused expansion into developed regions like the United States and Western Europe, where carrier channels and Apple hold dominant positions, preferring instead to consider entering via new product categories over a three-to-five-year horizon. In India, the focus shifts toward expanding presence in the premium segment above six hundred dollars. In short, Vivo’s international expansion remains focused primarily on mid-to-entry segments across emerging markets, offering thinner profit margins. A six percent decline in Southeast Asian regional shipments in 2025 serves as a clear reminder of these market dynamics. So where does the company go from here? Part of the answer is already visible in Vivo’s recent strategic adjustments. First, Vivo is reframing its presence in India, shifting from a direct asset-owning manufacturer to a brand, technology, and distribution coordinator. This setup preserves market share, protects cash flow, maintains a forty-nine percent financial yield, and allows its premium product plans to proceed as intended. This structural pivot is not mere external speculation; it is explicitly defined by the mechanics of the joint venture agreement. According to regulatory filings submitted by Dixon, the joint venture is mandated to carry out three specific operational functions: acquire selected manufacturing assets from Vivo, execute contract manufacturing and packaging agreements with Vivo India, and fulfill OEM orders—initially covering roughly two-thirds of Vivo’s local sales volume before opening up capacity to third-party brands. In other words, the joint venture functions as a contract manufacturer, while product R&D, branding, pricing strategy, and retail distribution remain controlled by Vivo India. Holding a forty-nine percent equity stake, Vivo transitions to an equity accounting model rather than full revenue consolidation while retaining proportional board representation to safeguard its governance voice. Simply put: manufacturing operations transfer to a locally controlled partner, while the commercial brand and retail business remain firmly in Vivo's hands. Maintaining market leadership, preserving operational cash flow, and collecting a forty-nine percent share of manufacturing profits represents a practical compromise designed to minimize disruption. Second, Vivo is actively establishing a multi-hub manufacturing and brand strategy. In late May 2025, Vivo launched its product line in São Paulo, Brazil, under the Jovi sub-brand name. Because the "Vivo" trademark was already registered by local telecom operator Telefônica, the company adapted by entering under an alternate brand identity. Manufacturing was assigned to a local partner, GBR, with production lines established in the Manaus Free Trade Zone that went operational in January 2025. Complemented by established market positions in Colombia, Chile, and Peru, Latin America is emerging as Vivo's next core strategic region. The Brazilian operating model serves as a template tailored for the post-India era: brand names can adapt, manufacturing can be outsourced to regional assembly partners, and market entry moves forward without exposing heavy physical assets to single-jurisdiction legal risk. The experience in India delivers a clear lesson on corporate asset ownership: deep operational localization alone is no longer an absolute defense, making governance structure and geographic diversification essential indicators of long-term resilience.7月24日，旭阳新材IPO即将上会。

时隔16年重返巅峰，斗牛士剑指双冠 对于西班牙而言，这场胜利不仅洗刷了2006年世界杯不敌法国的旧账，更是球队复兴的里程碑。

10、每5人中就有1人患癌！研究发现：做好这2件事，真能“改命”

莫德里奇的这次受伤恰逢米兰冲击欧冠名额的关键时期，目前红黑军团排名意甲第3，距离第5名的科莫和第6名的罗马有6分优势，在联赛还剩4轮的情况下，他们必须再拿到6分才能确保上岸（米兰与科莫和罗马的相互胜负关系均占优，因此同分情况下排名靠前）。

我认为他是世界级球员，真心这么觉得。

1、铸牢中华民族共同体意识龙江文学实践研讨会在哈尔滨学院胜利召开

特尔施特根急需稳定的出场机会，以重建比赛感觉，重新夺回在德国国家队的位置。

2、这样做，卵子、精子更健康优质！“好孕”宝典快查收~

美国黄金交易所分析师Jim Wyckoff的点评直指核心：“油价上涨推升债券收益率，收益率上扬，是黄金多头的敌人。

3、腰痛就拔罐？58岁糖友一“拔”，“拔”出酮症酸中毒

作为品牌深耕健康茶饮赛道、历经三轮持续迭代打磨的标志性单品，奈雪此次携手全球知名鲜果品牌佳沛，升级天然维C核心价值。健康日历俱乐部内部认为，约3000万欧元的转会费是兼顾竞技与财务利益的理想区间，既能带来可观的资本收益，又避免了低价抛售的损失。

4、专栏

近日，供应链先后传出两条重磅消息，引发行业热议。

5、这种藏在胃里的细菌，竟是肠癌“推手”！研究发现：肠癌风险升高近200%

2025年，替尔泊肽全年销售额365.07亿美元（降糖版229.65亿美元，减重版135.42亿美元），以4亿美元的优势超越司美格鲁肽，登顶全球药王。

6、凯恩：梅西可以是历史第一人！不要试图教梅西踢球！

拓竹未来或许能够凭更高的出货份额和更大的收入规模获得溢价，但从创想三维上市开始，市场不会再只为产品口碑和增长故事定价：收入结构、利润质量、现金流和增长持续性，都会被放到同一张表里比较。

这让行业感慨，众里寻他千百度，暮然回首，风口却在灯火阑珊处： 大模型公司的下一个主战场，可能不在代码里，视觉多模态，正在成为大模型公司下一个兵家必争之地。

在潜在人选中有三个最突出的名字，莱奥、帕夫洛维奇和普利西奇，三人的市场价都在5000万欧元左右。

7、美国急推航空收购禁令！“第二波中国冲击”逼出全面安全化？

2026年只用了半年，这个数变成了500亿到570亿元，同比增超22倍。

由于这名黑山小伙拥有高大的身形和高效的得分能力，球迷与媒体常将他与另一位从游击队走出的超级射手弗拉霍维奇相比较，而现在两人还拥有共同的经纪人里斯蒂奇。

8、超激烈半场！英阿大战19犯，创世界杯尴尬纪录，名记：丑陋至极

因此从材料上、读取信号的精度上，都需要实现核心突破。

豆包走的是一条“模拟点击”的路径，通过无障碍服务读取App内部的标签结构，再利用模拟触控功能自主操作App。

他曾主哨2024年欧冠决赛（皇马对阵多特蒙德）、2022年欧联杯决赛，并在2024年欧洲杯半决赛（西班牙对阵法国）中表现广受好评。

正是由于对阵亚特兰大时的出色表现，恩昆库如今最有希望在客战热那亚时首发，考虑到莱奥停赛，希门尼斯持续低迷，他的搭档可能会是菲尔克鲁格，两人本赛季仅在对阵那不勒斯的那场失利中联袂首发过一次。